Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Vasomedical, Inc. — Predicate Candidate Screening

7 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

88 daysmedian FDA review time
204 days90th percentile
7clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K111180VASOMEDICAL-BIOX 12- CHANNEL AMBULATORY ECG HOLTER RECORDER Vasomedical, Inc.2011-06-28620
K111096VASOMEDICAL-BIOX COMBINED 12 CHANNEL AMBULATORY ECG AND BLOOVasomedical, Inc.2011-06-24650
K092785COMBINED VASOMEDICAL-BIOX AMBULATORY ECG & BLOOD PRESSURE REVasomedical, Inc.2010-04-022040
K083820VASOMEDICAL BIOX CB-1305-C, 3 CHANNEL ECG HOLTER MONITOR, MOVasomedical, Inc.2009-04-011000
K033617EECP THERAPY SYSTEM MODEL TS4 WITH/WITHOUT PLUSE OXIMETRYVasomedical, Inc.2004-03-011040
K020857EECP THERAPY SYSTEM MODEL TS3 WITH PULSE OXIMETRY AND ENHANCVasomedical, Inc.2002-06-14880
K003469EECP THERAPY SYSTEM, MODEL TS3Vasomedical, Inc.2000-12-06280

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda